NCT02730299 2026-02-25
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Gamida Cell ltd
Phase 3 Completed
Clinical Trials
24 trialsNCT04620369 2025-12-03
Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy
Mayo Clinic
Phase 3 Completed
NCT03136445 2025-10-28
TREATT
NHS Blood and Transplant
Phase 3 Completed
NCT04260698 2025-07-02
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
Gamida Cell ltd
Phase 3 Completed
NCT03080883 2025-05-18
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
Phase 3 Completed
NCT01437787 2025-03-05
JAKARTA
Bristol-Myers Squibb
Phase 3 Completed
NCT03125070 2025-01-29
INSPIRE
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT02116530 2025-01-28
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01503515 2024-10-16
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
NCT05290545 2024-08-13
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT
Nanfang Hospital, Southern Medical University
Phase 3 Completed
NCT03800758 2023-05-06
Expressive Helping for Stem Cell Transplant Patients
Northwestern University
Phase 3 Completed
NCT02623309 2023-01-31
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients
Institut Paoli-Calmettes
Phase 3 Completed
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT01602211 2020-07-31
INSPIRE
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT02650791 2020-05-18
PATH
Ottawa Hospital Research Institute
Phase 3 Completed
NCT01231412 2019-10-24
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT00824993 2018-09-13
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT02635984 2018-08-20
FOND-O
Augusta University
Phase 3 Completed
NCT00893555 2017-01-12
VORI911
University Medical Center Groningen
Phase 3 Completed
NCT01237639 2016-10-12
TRIST
Ottawa Hospital Research Institute
Phase 3 Completed
NCT00833898 2015-12-09
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
University of Colorado, Denver
Phase 3 Completed
NCT00904995 2012-08-07
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00044759 2007-10-10
Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3 Completed
NCT00138112 2006-09-08
Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase 3 Completed